Cutaneous metastases in breast cancer
Pro Research Analysisby 
Searched over 200M research papers
Frequency and Clinical Significance of Cutaneous Metastases in Breast Cancer
Cutaneous metastases are more common in breast cancer than in other cancers among women, accounting for about 30% of all cutaneous metastasis cases, though they occur in only a minority of breast cancer patients overall Kalmykow2011Grecia2024Araújo2020. The incidence ranges from 0.6% to 10.4% of oncology patients, and while they often appear after the initial diagnosis and treatment, in rare cases, cutaneous metastases can be the first sign of breast cancer—even in patients with no prior cancer history Karaja2025Araújo2020Hail2024.
Clinical Presentation and Morphological Diversity of Skin Metastases
The appearance of cutaneous metastases from breast cancer is highly variable. They most commonly present as firm, flesh-colored to red nodules, papules, or plaques on the chest wall or breast, but can also appear as ulcerated, crusted, or smooth lesions Shrivastava2023Cohen2021Grecia2024+1 MORE. Less common sites include the eyelids, scalp, subungual nail bed, umbilicus, mastectomy scars, and radiation therapy ports Cohen2021Bricha2024. Classic patterns include carcinoma erysipelatoides, carcinoma telangiectoides, and carcinoma en cuirasse, with newer patterns like carcinoma hemorrhagiectoides also described Cohen2021Bricha2024.
These metastases can mimic a wide range of benign and malignant skin conditions, such as cellulitis, lymphedema, cysts, dermatofibromas, melanoma, non-melanoma skin cancers, and various infections or inflammatory skin diseases Kalmykow2011Cohen2021Bricha2024. This pleomorphic nature makes accurate diagnosis challenging and highlights the importance of considering cutaneous metastasis in any new or treatment-resistant skin lesion in breast cancer patients Cohen2021Bricha2024.
Diagnostic Approach and Importance of Early Detection
Diagnosis relies on careful clinical examination and confirmation by skin biopsy, often supported by immunohistochemical analysis Shrivastava2023Cohen2021Karaja2025+1 MORE. Early detection is crucial, as it can lower morbidity and slow disease progression, even though cutaneous metastases generally indicate incurable, advanced disease Kalmykow2011Shrivastava2023Karaja2025+1 MORE.
Prognosis and Molecular Associations
Cutaneous metastases from breast cancer are associated with highly malignant primary tumors, particularly those that are triple-negative or HER2-positive . Molecular markers such as underglycosylated MUC1 (uMUC1) and sialyl Lewis x (sLex) are more frequently found in primary tumors that develop cutaneous metastases, suggesting a role in the metastatic process . While the presence of skin metastases signals advanced disease, the prognosis is somewhat better than for cutaneous metastases from other internal malignancies .
Treatment Strategies and Quality of Life
There is no universally accepted standard of care for managing cutaneous metastases in breast cancer . Treatment is primarily palliative, focusing on delaying disease progression, controlling symptoms, and maintaining quality of life Kalmykow2011Shrivastava2023Huang2022. Options include systemic chemotherapy, hormonal therapy, radiotherapy, and, in select cases, surgical removal of skin lesions (cutaneous metastasectomy), though the role of surgery remains controversial Shrivastava2023Huang2022. Topical interventions and skin care are important for comfort and reducing distress .
Conclusion
Cutaneous metastases in breast cancer are a sign of advanced disease and can present in many different ways, often mimicking benign skin conditions. Early recognition and biopsy are essential for diagnosis. While treatment is mainly palliative, focusing on symptom control and quality of life, ongoing research into molecular markers and new therapies may improve outcomes for affected patients Kalmykow2011Shrivastava2023Cohen2021+7 MORE.
Sources and full results
Most relevant research papers on this topic